GlassScriptPhysician profile
Aureliano E Cifuentes
NPI 1679565519
$7,540.67
in general payments reported to CMS, 2019-2025
55 companies · $1,071 in 2025
The $1,071 reported for 2025 was more than what 90% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,817 · 2020: $644 · 2021: $901 · 2022: $777 · 2023: $981 · 2024: $1,350 · 2025: $1,071.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,401.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,000.58 | 2019-2023 | Ozempic, Rybelsus |
| Eisai INC. | $541.41 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $510.30 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $487.86 | 2019-2025 | Airsupra, Breztri, Xigduo |
| Pfizer INC. | $351.23 | 2019-2025 | |
| Daiichi Sankyo INC. | $345.03 | 2019-2025 | Injectafer |
| Corcept Therapeutics | $311.83 | 2023-2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $257.13 | 2022-2025 | |
| Amarin Pharma, INC. | $250.03 | 2019-2020 | |
| Amgen INC. | $248.11 | 2019-2025 | Repatha, Krystexxa, Otezla |
| Lucid Diagnostics INC. | $232.60 | 2021 | |
| Janssen Pharmaceuticals, INC | $232.12 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $222.51 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $193.07 | 2019-2023 | |
| Lilly USA, LLC | $188.41 | 2019-2025 | Mounjaro, Jardiance |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $159.44 | 2019-2025 | Xifaxan, Trulance |
| Abbvie INC. | $147.69 | 2021-2024 | Ubrelvy, Vraylar |
| Gilead Sciences, INC. | $143.45 | 2022-2025 | Epclusa, Yeztugo |
| Glaxosmithkline, LLC. | $129.14 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Intuity Medical INC | $122.77 | 2022 | |
| Baxter Healthcare | $115.12 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Therapeuticsmd, INC. | $104.56 | 2019 | |
| Sumitomo Pharma America, INC. | $96.64 | 2023-2025 | Gemtesa |
| Alnylam Pharmaceuticals INC. | $91.00 | 2025 | Givlaari |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.01 | 2019-2023 | |
| Xeris Pharmaceuticals, INC. | $73.47 | 2022-2025 | Recorlev, Keveyis |
| Abbott Laboratories | $67.62 | 2023-2025 | Proclaim, Freestyle Libre 3 |
| Mannkind Corporation | $60.89 | 2020-2024 | |
| Lundbeck LLC | $56.35 | 2023 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $55.57 | 2025 | Rexulti |
| Insulet Corporation | $48.03 | 2023 | Omnipod |
| Dexcom, INC. | $47.51 | 2024-2025 | Dexcom G6 Transmitter |
| Mylan Specialty L.P. | $46.33 | 2024 | Yupelri |
| Boston Scientific Corporation | $42.76 | 2024-2025 | Ams 700 |
| Astellas Pharma US INC | $42.38 | 2023-2024 | Myrbetriq, Veozah |
| Medtronic, INC. | $40.75 | 2022-2023 | Intellis Adaptivestim |
| Merck Sharp & Dohme LLC | $39.80 | 2019 | |
| Philips North America LLC | $38.08 | 2019-2020 | |
| Exact Sciences Corporation | $26.45 | 2024 | Cologuard Collection Kit |
| Actelion Pharmaceuticals US, INC. | $23.42 | 2024 | Uptravi, Opsumit |
| Sanofi Pasteur INC. | $23.21 | 2019 | |
| Valeritas, INC. | $23.15 | 2019 | |
| Ethicon INC. | $22.37 | 2024 | Monarch Platform |
| Radius Health, INC. | $22.18 | 2021 | |
| Acella Pharmaceuticals, LLC | $20.49 | 2024 | NP Thyroid 60 |
| Strongbridge US INC. | $18.15 | 2020 | |
| Silk Road Medical, INC. | $17.31 | 2019 | |
| Antares Pharma, INC. | $16.17 | 2020 | |
| Seqirus USA INC | $14.86 | 2019 | |
| Inspire Medical Systems, INC. | $14.82 | 2025 | Inspire |
| Phadia US INC. | $14.82 | 2020 | |
| Abiomed | $14.81 | 2025 | |
| Allergan, INC. | $13.76 | 2020 | |
| Evoke Pharma, INC. | $13.54 | 2025 | |
| Vistapharm, INC. | $12.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aureliano Cifuentes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.